Study on the anti-gout activity of isoastilbin

Lihong ZHANG,Zichun DENG,Jia FANG,Lanzhou LI,Yan LIU
DOI: https://doi.org/10.13463/j.cnki.jlzyy.2018.10.025
2018-01-01
Abstract:Objective Anti-gout activity and mechanism of isoastilbin (IA) were studied by gout animal models. Methods The rat model of gouty arthritis was established by intra-articular injection of Monosodium Urate (MSU). The activity of anti-gouty arthritis in IA was evaluated through the swelling of the ankle joint and the factors of inflammation related factors. The mice model of hyperuricemia was established by intraperitoneal injection of oxazine potassium, serum uric acid (UA) content and xanthine oxidase (XOD) activity were measured to evaluate the anti-hyperuricemia activity of IA. Results IA treatment significantly reduced the joint swelling of gouty arthritis rats by more than 5.7%, and inflammatory factors IL-1β, IL-8, MCP-1, IFN-γ decreased significantly (P<0.05), and could effectively reduce the infiltration of inflammatory cells, while IA treatment significantly reduced the serum UA 25.8% and XOD activity of 12.9% in hyperuricemia mice. Conclusion IA can inhibit gouty arthritis by lowering the level of inflammation, and reduce the activity of XOD by reducing the level of UA to achieve anti-hyperuricemia.
What problem does this paper attempt to address?